About Us
Board of Directors
Dana Mead, Partner, Kleiner Perkins Caufield & Byers
Dana Mead joined Kleiner Perkins Caufield & Byers as a partner in May 2005 to work in the life sciences practice.
For the past two decades, Mead's career has focused on identifying new medical technologies, developing new markets and therapies, and building world-class management teams. He has worked with physician thought leaders around the world representing 10 different medical specialties. At KPCB, he leverages experience gained from his venture-funded, start-up management roles and board participation to support entrepreneurs and innovators dedicated to making a real difference in the lives of millions suffering from life-limiting disease.
Prior to joining KPCB, Mead was President of Guidant Vascular Intervention, a fully integrated billion dollar division with over 4500 employees. Since joining Guidant in 1992, he held positions of increasing responsibility including Vice President and General Manager, Cardiac & Vascular Surgery; Vice President and General Manager, Stents, Vascular Intervention Group; President, Japan and A/P Operations based in Tokyo; and Vice President, Corporate Relations and Policy with responsibility for investor relations, corporate communications, corporate marketing and public policy initiatives. Prior to joining Guidant, Mead worked in various sales and marketing roles at Allergan, Inc. and Johnson & Johnson. A native of Connecticut, he received his bachelor's degree from Lafayette College and holds an MBA degree from the University of Southern California. Mead serves on the boards of the California Healthcare Institute (CHI), the Cardiovascular Research Foundation (CRF), AesThera, Inc., Sonitus, Amigo Therapy, OtisMed Corporation and Lucille Packard Children's Hospital (LPCH).
Lissa Goldenstein, President and CEO, Living MicroSystems
Lissa Goldenstein is an entrepreneurial executive with more than 28 years of experience bringing new technology to new markets. She is currently president and chief executive officer of Living MicroSystems, Inc., which is an early stage medical diagnostic company focused on providing pregnant women and their physicians with accurate, timely and reliable information regarding fetal well-being. Prior to joining Living MicroSystems, Goldenstein served as the President and Chief Executive Officer of Argonaut Technologies, Inc (NASDAQ, AGNT) which was sold to Biotage AB of Sweden in June 2005. Prior to her CEO position, Goldenstein lead the commercial activities for Argonaut from 1998, when it was an early stage, venture backed company, through its initial public offering in 2000. Argonaut Technologies was the leading provider of instruments and reagents that enable chemists in the pharmaceutical industry to find and develop new drugs. Prior to joining Argonaut, Goldenstein was senior vice president of worldwide sales, marketing and service with Molecular Simulations Incorporated, the largest provider of molecular modeling software for the pharmaceutical and chemical industries. From 1981 through 1991, she directed sales activities for McDonnell Douglas Corporation, and was responsible for sales of the first CAD/CAM systems sold to designers in the building, engineering and manufacturing industries. Goldenstein has a B.S. in engineering from Pennsylvania State University. She is currently on the Board of Directors for Living MicroSystems, Argonaut Technologies and OtisMed Corporation.
Dr. Charlie Chi, Chief Executive Officer & Chairman
Dr. Chi is an engineer and business entrepreneur who founded OtisMed Corp. to address unsolved clinical problems in orthopedics. He brings more than 10 years of management, marketing, product development and consulting experience in the medical device and high technology industries to his role as chief executive officer.
Before OtisMed, Dr. Chi was a senior analyst at OnWorld Inc., where he led the company’s research and reporting on the wireless sensor market. He has also held senior engineering and management positions at companies including Thoratec Corp., Wren Technologies, Agilent Technologies, C Speed Corp. and Integrated Surgical Systems (ISS).
